Onglyza2018-04-03T19:23:29-04:00

Onglyza

A recent safety study of the drug Onglyza (saxagliptin) revealed a 27 percent increase in the rate of hospitalization for heart failure in those patients taking Onglyza in the study.  The study also revealed a risk of death in the Onglyza-treated patients.  Following the study, an FDA advisory committee voted to update the label of Onglyza to warn patients of the potential for an increased risk of heart failure.  Our firm investigates cases of heart failure or death in patients taking Onglyza or saxagliptin.

We are leaders in pursuing medical product liability lawsuits involving unsafe drugs and medical devices, and we offer free investigations into these cases for individuals like you. No payment is required until compensation is collected on your behalf. If you or a loved one has suffered as a result of taking Onglyza, don’t suffer alone–we’re here to help you.

The T.J. Preuss Law Firm is experienced, innovative and determined to provide brighter futures for those hurt by companies that value profit over safety. Give us a call at 816-307-2788; the road to healing starts today.

Preuss | Foster Law has offices in Missouri and Kansas. We serve clients in all areas of Missouri, including the Kansas City and St. Louis metro area, Columbia, Springfield, Sedalia, Cape Girardeau, and Joplin.  We also serve clients throughout the state of Kansas, including Lawrence, Topeka, Wichita, Salina and Manhattan. Call us today for your complimentary consultation.